Profusa, Inc. Common Stock (PFSA)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $271,330
Last updated: Nov 17, 2026 at 11:06 AM ET
Earnings
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 70.6% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 31.0, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about PFSA
News
PFSA Valuation
- P/B
- -0.0x
PFSA Profitability: Margins, ROIC and FCF
Profusa, Inc. Common Stock (PFSA) has an operating margin of 0.0% and a net margin of 0.0%. It posts 220.0% ROIC.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROIC
- 220.0%
- ROE
- 0.0%
Profusa, Inc. Common Stock Competitors
The companies most similar to Profusa, Inc. Common Stock (PFSA) include Catheter Precision, Safeplus International Holdings and Hyperfine.
Sector: Healthcare
Companies most similar to Profusa, Inc. Common StockPFSA Bull Case vs Bear Case
Bull case
- PFSA earns a 220.0% return on invested capital.
PFSA Earnings Date
PFSA reports Apr 13, 2027. The date is estimated.
Updated Nov 13, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About PFSA
When does PFSA report earnings?
Profusa, Inc. Common Stock (PFSA) is expected to report earnings on Apr 13, 2027.
Does PFSA pay dividends?
Profusa, Inc. Common Stock (PFSA) does not currently pay a regular dividend.
What is PFSA's market cap?
Profusa, Inc. Common Stock (PFSA) has a market capitalization of $271,330 with a current stock price of $0.41.
PFSA pages: Overview, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.